Exploratory observational study of famitinib malate combined with carrillizumab in third-line and post-third-line treatment of colorectal cancer
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: Single arm:camrelizumab combined with famitinib Primary outcome(s): Overall Survival Study Design: Single arm
创建时间：
2020-05-15
